|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li J, Liu Y, Jin J, Shi Q, Ji Y, Zhang B
and Hu P: Study on clinicopathological features and risk factors of
patients with multiple primary breast cancers and thyroid disease.
Mediators Inflamm. 2023:31335542023. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bolf EL, Sprague BL and Carr FE: A linkage
between thyroid and breast cancer: A common etiology? Cancer
Epidemiol Biomarkers Prev. 28:643–649. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Huang NS, Chen XX, Wei WJ, Mo M, Chen JY,
Ma B, Yang SW, Xu WB, Wu J, Ji QH, et al: Association between
breast cancer and thyroid cancer: A study based on 13 978 patients
with breast cancer. Cancer Med. 7:6393–6400. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abdou AG and Asaad NY:
Lymphoepithelioma-like carcinoma of the breast: Cytological,
histological, and immunohistochemical characteristics. Diagn
Cytopathol. 43:210–213. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rao AA, Feneis J, Lalonde C and
Ojeda-Fournier H: A pictorial review of changes in the BI-RADS
fifth edition. Radiographics. 36:623–639. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Giuliano AE, Connolly JL, Edge SB,
Mittendorf EA, Rugo HS, Solin LJ, Weaver DL, Winchester DJ and
Hortobagyi GN: Breast cancer-major changes in the american joint
committee on cancer eighth edition cancer staging manual. CA Cancer
J Clin. 67:290–303. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Perrier ND, Brierley JD and Tuttle RM:
Differentiated and anaplastic thyroid carcinoma: Major changes in
the American joint committee on cancer eighth edition cancer
staging manual. CA Cancer J Clin. 68:55–63. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Mullighan CG, Easton J, Roberts S,
Heatley SL, Ma J, Rusch MC, Chen K, Harris CC, Ding L, et al: CREST
maps somatic structural variation in cancer genomes with base-pair
resolution. Nat Methods. 8:652–654. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nanev V, Naneva S, Yordanov A, Strashilov
S, Konsoulova A, Vasileva-Slaveva M, Betova T and Ivanov I:
Lymphoepithelioma-like carcinoma of the breast synchronous with a
high-grade invasive ductal carcinoma and ductal carcinoma in situ
in a different quadrant of the same breast: A case report. Medicina
(Kaunas). 58:11462022. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kumar S and Kumar D:
Lymphoepithelioma-like carcinoma of the breast. Mod Pathol.
7:129–131. 1994.PubMed/NCBI
|
|
12
|
Nieto-Coronel MT, Perez-Sanchez VM,
Salazar-Campos JE, Diaz-Molina R and Arce-Salinas CH:
Lymphoepithelioma-like carcinoma of breast: A case report and
review of the literature. Indian J Pathol Microbiol. 62:125–128.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koufopoulos N, Syrios J, Papanikolaou A,
Misitzis I, Kapatou KA, Dimas D and Khaldi L:
Lymphoepithelioma-like breast carcinoma. Pol J Pathol. 69:98–104.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J and Liang L: The association between
thyroid and breast cancers: A bidirectional mendelian randomization
study. Front Endocrinol (Lausanne). 14:11854972023. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kohler C, Chang M, Allemann-Su YY, Vetter
M, Jung M, Jung M, Conley Y, Paul S, Kober KM, Cooper BA, et al:
Changes in attentional function in patients from before through 12
months after breast cancer surgery. J Pain Symptom Manage.
59:1172–1185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Diao Y, Wang R, Cui J, Jin C, Chen Y and
Li X: Risk factors for secondary thyroid cancer in patients with
breast cancer: A propensity-matched SEER analysis. Sci Rep.
14:126792024. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Halada S, Casado-Medrano V, Baran JA,
Baran JA, Lee J, Chinmay P, Bauer AJ and Franco AT: Hormonal
crosstalk between thyroid and breast cancer. Endocrinology.
163:bqac0752022. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cybulski C, Nazarali S and Narod SA:
Multiple primary cancers as a guide to heritability. Int J Cancer.
135:1756–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sabapathy K and Lane DP: Therapeutic
targeting of p53: All mutants are equal, but some mutants are more
equal than others. Nat Rev Clin Oncol. 15:13–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Manzella L, Stella S, Pennisi MS, Tirrò E,
Massimino M, Romano C, Puma A, Tavarelli M and Vigneri P: New
insights in thyroid cancer and p53 family proteins. Int J Mol Sci.
18:13252017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yi D, Xu L, Luo J, You X, Huang T, Zi Y,
Li X, Wang R, Zhong Z, Tang X, et al: Germline TP53 and MSH6
mutations implicated in sporadic triple-negative breast cancer
(TNBC): A preliminary study. Hum Genomics. 13:42019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Grawenda AM, Møller EK, Lam S, Repapi E,
Teunisse AF, Alnæs GI, Børresen-Dale AL, Kristensen VN, Goding CR,
Jochemsen AG, et al: Interaction between p53 mutation and a somatic
HDMX biomarker better defines metastatic potential in breast
cancer. Cancer Res. 75:698–708. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ragu ME, Lim JMC, Ng PS, Yip CH, Rajadurai
P, Teo SH and Pan JW: TP53 somatic mutations in Asian breast cancer
are associated with subtype-specific effects. Breast Cancer Res.
25:482023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Luo K, Qian Z, Jiang Y, Lv D, Zhu K, Shao
J, Hu Y, Lv C, Huang Q, Gao Y, et al: Characterization of the
metabolic alteration-modulated tumor microenvironment mediated by
TP53 mutation and hypoxia. Comput Biol Med. 163:1070782023.
View Article : Google Scholar : PubMed/NCBI
|
